Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

Acting FDA chief Janet Woodcock defended FDA’s efforts to respond to the opioid epidemic, while also saying opioid overprescribing is still a problem that requires a change in prescriber behavior.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.